The British Heart Foundation (BHF) has invested £290,000 (€365,000) in a vitamin K trial investigating its potential to reduce heart problems in people with chronic kidney disease (CKD).
from NutraIngredients RSS http://ift.tt/1qvkNNg
via IFTTT
information on Dietary Supplements
The British Heart Foundation (BHF) has invested £290,000 (€365,000) in a vitamin K trial investigating its potential to reduce heart problems in people with chronic kidney disease (CKD).